Senior Scientific Manager
Syd manages the high-throughput operations within the Garnett Group. These include drug sensitivity screens both single agents and combinations in cell line and organoids models as well as CRISPR knockout screens.
I have over ten years of cancer research experience working on high-throughput genomic & cell based projects at the Sanger Institute. In addition I helped to establish the Cell Model Passports, a website providing annotation, genomics and functional datasets for the cancer models used as part of the Cancer Dependency Map at Sanger.